Pinnacle Wealth Planning Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Pinnacle Wealth Planning Services's REGN Position: Q3 2026 in Review
Pinnacle Wealth Planning Services reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q3 2026, selling an estimated $5.29K and leaving 533 shares worth $404K. The position accounts for 0.04% of the portfolio, ranked #276.
Pinnacle Wealth Planning Services first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $643K in Q3 2024. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Pinnacle Wealth Planning Services held 533 shares of Regeneron Pharmaceuticals worth $404K as of Q3 2026.
- Pinnacle Wealth Planning Services sold 7 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $5.29K.
- Regeneron Pharmaceuticals made up 0.04% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #276 holding.
- Pinnacle Wealth Planning Services first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
- Pinnacle Wealth Planning Services's Regeneron Pharmaceuticals position peaked at $643K in Q3 2024.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.